The latest announcement is out from Jiangsu Recbio Technology Co., Ltd. Class H ( ($HK:2179) ). Jiangsu Recbio Technology Co., Ltd. has received ...
Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback